Bioorganic and Medicinal Chemistry Letters p. 5633 - 5638 (2006)
Update date:2022-08-05
Topics:
Chen, Jack J.
Thakur, Kumar D.
Clark, Michael P.
Laughlin, Steven K.
George, Kelly M.
Bookland, Roger G.
Davis, Jan R.
Cabrera, Edward J.
Easwaran, Vijay
De, Biswanath
George Zhang
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3.
View MoreContact:+86-21-38682181
Address:shanghai ,china
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Fuxin Jintelai Fluorin Chemical Co., Ltd.
Contact:+86-0418-8229599
Address:, 7th Huagong Road, Fluorine industry development zone (Yimatu Town,Fumeng County),Fuxin City, Liaoning Province, China
HaiNan Periwinkle Pharmaceutical Co.,Ltd.
website:http://www.cchpharm.com/en/index.html
Contact:020-82208978
Address:Gongye road,Wuzhishan city,HaiNan province
Shanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
Doi:10.1016/S0008-6215(00)90732-8
(1985)Doi:10.1002/open.201800296
(2019)Doi:10.1016/j.molstruc.2007.03.022
(2008)Doi:10.1002/ejoc.201101763
(2012)Doi:10.1016/j.jorganchem.2007.04.029
(2007)Doi:10.1016/j.jorganchem.2007.06.019
(2007)